The major histocompatibility complex (MHC) (Chromosome 6p21.3) is a dynamic, immune gene-rich region that is associated with multiple diseases. Haplotype-tagging single-nucleotide polymorphism (htSNP) panels for the MHC can aid association studies but have only been reported for African, Asian and Caucasian populations to date. We genotyped 2154 SNPs spanning a 3.8-Mb region of the classical MHC in 94 healthy African Americans using Illumina BeadArray technology. We describe the haplotype structure of the MHC in African Americans, calculate the recombination rate (0.35 cM Mb
Introduction
The major histocompatibility complex (MHC), an immune gene-dense region on Chromosome 6p21.3, 1 is a prime candidate for disease association studies. Examples of clinical conditions associated with the MHC include tissue transplant rejection, differential drug response, metabolic disease, psychiatric disorders, susceptibility to infection and autoimmunity. 2 Relating causative alleles from the MHC to clinical phenotypes are complicated due to extreme levels of polymorphism, high gene density, linkage disequilibrium (LD), reduced recombination and gene clustering. Many studies have compensated for these complications by constructing detailed LD maps to allow haplotypetagging of SNPs (single-nucleotide polymorphisms) (htSNPs); [3] [4] [5] [6] however, these studies have, to date, only focused on continental African, Asian or Caucasian populations.
African Americans, a recently admixed population with genetic ancestry attributable to both Africa and Europe, have not been evaluated for LD and recombination in the MHC region. Allele frequencies can differ significantly between populations especially with ancestry from different continents, 7 as can be observed at numerous loci between continental Africans, Europeans and African Americans. While these differences allow the use of ancestry informative markers for disease association studies, 8, 9 they preclude the use of htSNPs designed for one population to be universally informative in another. Therefore, in genetic association studies, htSNP panels based on HapMap Africans (Yoruba) or Caucasians (Utah) are not adequate to capture all data for an African-American population. 7 In this study, we evaluate a 3.8-Mb region of the MHC, spanning from GABBR1 to KIFC1 (NCBI Build 36, chromosome 6: 29673644-33486512), for LD and recombination by using a panel of 2045 putative htSNPs, designed to capture variation polymorphic in either continental African or European populations, in 93 healthy self-identified African Americans from the southeastern United States. 10 This work allowed us to identify recombination hot spots and to suggest an efficient htSNP panel for MHC-based genetic association studies in African Americans.
Results and discussion
Marked LD and recombination in the MHC generate a challenge in designing genetic association studies. Since LD patterns are population specific, development of ethnic-specific htSNP panels and detailed understanding of LD and recombination across the MHC in multiple populations are useful. This is especially true for recently admixed groups such as African Americans since selective pressures unique to the geographic origins of each population 11 can alter frequencies of MHC alleles. 12 Minor allele frequencies (MAFs) range widely between HapMap Yoruba (YRI), HapMap European (CEU) and our African-American populations at many loci in this study, with an average difference of 0.117 between African Americans and CEU and 0.062 between Africans Americans and YRI (see Figure 1 ). These differences highlight the pitfall of using continental African (YRI) or European (CEU) data regarding allele frequencies, LD or haplotype tagging in a group that derives genetic ancestry from multiple populations, such as African Americans.
In respect to genotyping results for our 94 AfricanAmerican samples, we attempted genotyping on 2154 htSNPs, which captured information on 97% of the 10 342 HapMap SNPs in this region. Of those, 2045 htSNPs (95.3%) and 93 samples (98.9%) were genotyped successfully. We used 2023 htSNPs in further analyses since 22 SNPs were excluded due to low variation.
We measured pairwise LD with the D 0 statistic to determine haplotype structure and identified 222 haplotype blocks with an average size of 7.65 kb across the ), and haplotypes were deduced using PHASE2.1 software 13 (200 iterations; thinning interval ¼ 2; 100 burn-in iterations). To increase estimation accuracy, we made final runs 10 times longer. We identified all nonredundant haplotypes having a frequency X0.10 and consisting of at least 10 SNPs that are likely to represent the nonrecombinant descendants from a single ancestor. Red triangles indicate the recombination hot spots with strong statistical support estimated from LDHat. The horizontal green lines indicate the extent of nonredundant haplotypes having a frequency of at least 10% and consisting of at least 10 SNPs. Recombination hot spot densities (the number of hot spots per kilobase per iteration) were estimated using LDHat v2.0 rhomap 14 (1.1 million iterations with a burn-in 100 000 iterations and sampled every 1000 iterations). Both the haplotype block and hot spot penalties were set to zero. All statistical analyses were performed using SAS v9.0 (SAS Institute, Cary, NC, USA). See the online version for color figure. MHC (see Figure 2) . We found that recombination rate across the African-American MHC was reduced from the genome average (African- TAP2) . These data provide visible peaks in the recombination rates around each hot spot (see Figure 3) .
Given the variation in allele frequencies between African, European and African-American populations, a haplotype-tagging panel specific to this group is needed for high-density genotyping in the MHC. Therefore, we suggest 1384 validated htSNPs that capture over 95% of SNP variation in the MHC of African Americans (provided as Supplementary material). Currently, commercially available MHC-centric panels (such as the 1239 SNP Illumina MHC panel set) base SNP selection on Caucasians (CEPH) and only capture 37.9% of variation in the African-American MHC. Chip-based genotyping assays also do not adequately provide coverage for African Americans in this region; the Affymetrix 500K GeneChip contains 247 SNPs located in this 3.8-Mb region.
In summary, we report here the first LD map and estimates of recombination rates of the MHC in African Americans. Given the interest in investigating genetic susceptibility of the MHC in multiple populations and minority groups, we believe our htSNP panel will prove a valuable resource for future genetic association studies.
